1 |
Kim SJ, Park SE, Lee C, et al (2003). Altered imprinting, promoter usage, and expression of insulin-like growth factor-II gene in gestational trophoblastic diseases. Gynecol Oncol, 88, 411-8.
DOI
|
2 |
Li HW, Tsao SW, Cheung AN (2002). Current understandings of the molecular genetics of gestational trophoblastic diseases. Placenta, 23, 20-31.
DOI
|
3 |
Mutter GL, Stewart CL, Chaponot ML, Pomponio RJ (1993). Oppositely imprinted genes H19 and insulin-like growth factor 2 are coexpressed in human androgenetic trophoblast. Am J Hum Genet, 53, 1096-102.
|
4 |
Steinberg KM, Schneider VA, Graves-Lindsay TA, et al (2014). Single haplotype assembly of the human genome from a hydatidiform mole. Genome Res, 24, 2066-76.
DOI
|
5 |
Zhang Y, Shields T, Crenshaw T, et al (1993) Imprinting of human H19: allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching. Am J Hum Genet, 53, 113-24.
|
6 |
Arima T, Matsuda T, Takagi N, Wake N (1997). Association of IGF2 and H19 imprinting with choriocarcinoma development. Cancer Genet Cytogenet, 93, 39-47.
DOI
|
7 |
Ariel I, Lustig O, Oyer CE, et al (1994). Relaxation of imprinting in trophoblastic disease. Gynecol Oncol, 53, 212-9.
DOI
|
8 |
Biscaro A, Braga A, Berkowitz RS (2015). Diagnosis, classification and treatment of gestational trophoblastic neoplasia. Rev Bras Ginecol Obstet, 37, 42-51
DOI
|
9 |
Cui SJ, Tewari M, Schneider T, Rubin R (1997). Ethanol promotes cell death by inhibition of the insulin-like growth factor I receptor. Alcohol Clin Exp Res, 21, 1121-72
DOI
|
10 |
Hall JG (1990) Genomic imprinting: review and relevance to human diseases. Am J Hum Genet, 46,857-73.
|
11 |
Kolomietz E, Maire G, Nanji S,et al (2015). Placental molar disease: what are the benefits and barriers to the adoption of a comprehensive diagnostic service? Int J Gynecol Pathol, 34, 411-8.
DOI
|